Insulin-like growth factor-I is an important antiapoptotic factor for rat leydig cells during postnatal development

Endocrinology. 2007 Jan;148(1):128-39. doi: 10.1210/en.2006-0835. Epub 2006 Oct 5.

Abstract

The present investigation examines the influence of IGF-I and the role of IGF-I receptor (IGF-IR) in the apoptosis/survival of Leydig cells. Immunohistochemical analysis of the rat testis at different ages revealed that the level of the phosphorylated IGF-IR increases from birth to d 20 of postnatal life, remaining high in the adult testis. Western blotting revealed that this level is higher in Leydig cells isolated from 40-d-old than from 10- or 60-d-old rats. Application of the terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assay revealed that IGF-I decreases the level of apoptosis in Leydig cells at all stages of development, and the selective inhibitor of IGF-IR, picropodophyllin, blocks this antiapoptotic effect. The mechanism underlying the antiapoptotic action of IGF-I involves the phosphatidylinositol 3-kinase/Akt pathway, and in immature Leydig cells, this growth factor enhances the expression of Bcl-2 and cellular inhibitor of apoptosis proteins 2, while preventing activation of caspase-3 by cleavage. Furthermore, IGF-II and high concentrations of insulin also evoke phosphorylation of IGF-IR and, like IGF-I, enhance the expression of the steroidogenic acute regulatory protein by Leydig cells. Inhibition of IGF-IR by picropodophyllin decreases the survival of Leydig cells, both in the presence and absence of IGF-I, demonstrating that signaling via the IGF-IR plays an important role in Leydig cell survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • DNA / biosynthesis
  • Flavonoids / pharmacology
  • Immunohistochemistry
  • Insulin-Like Growth Factor I / metabolism*
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor II / pharmacology
  • Leydig Cells / cytology*
  • Leydig Cells / metabolism*
  • Male
  • Phosphorylation / drug effects
  • Podophyllotoxin / analogs & derivatives
  • Podophyllotoxin / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, IGF Type 1 / antagonists & inhibitors
  • Receptor, IGF Type 1 / metabolism
  • Testis / cytology
  • Testis / growth & development*
  • Testis / physiology
  • Wortmannin

Substances

  • Androstadienes
  • Flavonoids
  • Protein Kinase Inhibitors
  • picropodophyllin
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • DNA
  • Receptor, IGF Type 1
  • Podophyllotoxin
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Wortmannin